| EPB0277 | Impact of COVID-19 pandemic on HIV viral load testing in paediatric HIV clinics in the European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC) | E-poster | SARS-CoV-2, COVID-19 and HIV |
| EPB0276 | Pretreatment drug resistance and molecular epidemiology of HIV-1 across the Philippines | E-poster | ART resistance |
| EPB0275 | Interpretation of doravirine resistance by algorithm in antiretroviral-naïve people with HIV in Haiti | E-poster | ART resistance |
| EPB0274 | Subtype A1, D, and recombinant HIV-1 natural polymorphisms associated with lenacapavir drug resistance in Mbarara, Uganda | E-poster | ART resistance |
| EPB0273 | Assessment of prevalence, patterns, and risk factors of HIV drug resistance among pregnant women living with HIV in Tanzania | E-poster | ART resistance |
| EPB0272 | Prevalence and dynamics of drug resistance during dolutegravir-containing treatment in a pediatric population living with HIV-1 (IMPAACT P1093) | E-poster | ART resistance |
| EPB0271 | Assessment of transmitted drug resistance mutations to doravirine (MK-1439) in Argentina | E-poster | ART resistance |
| EPB0270 | Effects of oral cannabinoids on systemic inflammation and viral reservoirs in people with HIV on antiretroviral therapy: results of the CTNPT 028 clinical trial | E-poster | Other strategies and therapies |
| EPB0269 | Review of antiretroviral therapy coverage among prisoners living with HIV in 10 African countries | E-poster | Clinical issues specific to key populations |
| EPB0268 | The role of substance use in structural heart disease among unsheltered and unstably housed women living with HIV | E-poster | Clinical issues specific to key populations |